Sign In
Buy TTI
$7.70
+0.0800 (+1.05%)
At Close: Jul 31, 2026
Thiogenesis Announces Grant of Stock Options
10:01am, Thursday, 12'th Jun 2025
San Diego, California--(Newsfile Corp. - June 12, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
09:00am, Thursday, 12'th Jun 2025
THE WOODLANDS, Texas , June 12, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will be participating in two investor conferenc
San Diego, California--(Newsfile Corp. - June 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing
TETRA TECHNOLOGIES, INC. TO HOST INVESTOR DAY ON SEPTEMBER 25, 2025, AT THE NEW YORK STOCK EXCHANGE
04:30pm, Tuesday, 10'th Jun 2025
TETRA Oasis Total Desalination Solution (TDS) Receives 2025 Hart Energy Special Meritorious Engineering Award for Innovation THE WOODLANDS, Texas , June 10, 2025 /PRNewswire/ -- TETRA Technologies,
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
08:00am, Tuesday, 27'th May 2025
HOUSTON--(BUSINESS WIRE)-- #IdiopathicPulmonaryFibrosis--Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral,
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
08:00am, Tuesday, 27'th May 2025
THE WOODLANDS, Texas , May 27, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will be participating in two investor conference
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS SPRING 2025 INVESTOR CONFERENCE
08:00am, Thursday, 22'nd May 2025
THE WOODLANDS, Texas , May 22, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will participate at the Virtual Lytham Partners
Thiogenesis Initiates Phase 2 Clinical Trial in Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like Episodes ("MELAS")
09:00am, Wednesday, 14'th May 2025
San Diego, California--(Newsfile Corp. - May 14, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing d
Tetra Technologies Announces Participation in the D. Boral Capital Inaugural Global Conference
02:00pm, Tuesday, 06'th May 2025
The Woodlands, Texas--(Newsfile Corp. - May 6, 2025) - Tetra Technologies (NYSE: TTI) today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025,
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE D.
04:30pm, Monday, 05'th May 2025
THE WOODLANDS, Texas , May 5, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that its senior management will participate at the D. Boral Capital Inaugura
TETRA Technologies, Inc. (TTI) Q1 2025 Earnings Call Transcript
01:51pm, Wednesday, 30'th Apr 2025
TETRA Technologies, Inc. (NYSE:TTI ) Q1 2025 Results Conference Call April 30, 2025 10:30 AM ET Company Participants Kurt Hallead - VP, Treasurer and Head of Investor Relations Brady Murphy - Presiden
Tetra Technologies (TTI) Surpasses Q1 Earnings and Revenue Estimates
07:10pm, Tuesday, 29'th Apr 2025
Tetra Technologies (TTI) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.05 per share a year ago.
TETRA TECHNOLOGIES, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS AND UPDATES FIRST-HALF 2025 GUIDANCE
05:00pm, Tuesday, 29'th Apr 2025
First Quarter 2025 Financial Highlights Revenue of $157 million increased 17% sequentially Net income before taxes and discontinued operations of $5.1 million decreased $2.3 million sequentially from
TETRA TECHNOLOGIES, INC. ANNOUNCES EXPANSION OF SMACKOVER FORMATION EVERGREEN UNIT AND UPDATE ON ADDITIONAL TEST WELL RESULTS
08:00am, Thursday, 24'th Apr 2025
THE WOODLANDS, Texas , April 24, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced that on April 22, 2025 the Arkansas Oil & Gas Commission ("AOGC") approv
Tetra Technologies (TTI) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 22'nd Apr 2025
Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
